BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 16630294)

  • 1. Reduced syndecan-1 expression is correlated with the histological grade of malignancy at the deep invasive front in oral squamous cell carcinoma.
    Kurokawa H; Zhang M; Matsumoto S; Yamashita Y; Tanaka T; Takamori K; Igawa K; Yoshida M; Fukuyama H; Takahashi T; Sakoda S
    J Oral Pathol Med; 2006 May; 35(5):301-6. PubMed ID: 16630294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship of the histologic grade at the deep invasive front and the expression of Ki-67 antigen and p53 protein in oral squamous cell carcinoma.
    Kurokawa H; Zhang M; Matsumoto S; Yamashita Y; Tanaka T; Tomoyose T; Takano H; Funaki K; Fukuyama H; Takahashi T; Sakoda S
    J Oral Pathol Med; 2005 Nov; 34(10):602-7. PubMed ID: 16202080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of syndecan-1 with tumor grade and histology in primary invasive cervical carcinoma.
    Rintala M; Inki P; Klemi P; Jalkanen M; Grénman S
    Gynecol Oncol; 1999 Dec; 75(3):372-8. PubMed ID: 10600292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The level of syndecan-1 expression is a distinguishing feature in behavior between keratoacanthoma and invasive cutaneous squamous cell carcinoma.
    Mukunyadzi P; Sanderson RD; Fan CY; Smoller BR
    Mod Pathol; 2002 Jan; 15(1):45-9. PubMed ID: 11796840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced expression of syndecan-1 in the stroma of head and neck squamous cell carcinoma.
    Mukunyadzi P; Liu K; Hanna EY; Suen JY; Fan CY
    Mod Pathol; 2003 Aug; 16(8):796-801. PubMed ID: 12920224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syndecan-1 expression has prognostic significance in head and neck carcinoma.
    Anttonen A; Kajanti M; Heikkilä P; Jalkanen M; Joensuu H
    Br J Cancer; 1999 Feb; 79(3-4):558-64. PubMed ID: 10027330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between reduction of syndecan-1 expression and clinico-pathological parameters in squamous cell carcinoma of tongue.
    Ro Y; Muramatsu T; Shima K; Yajima Y; Shibahara T; Noma H; Shimono M
    Int J Oral Maxillofac Surg; 2006 Mar; 35(3):252-7. PubMed ID: 16280239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The high prognostic value of the histologic grade at the deep invasive front of tongue squamous cell carcinoma.
    Kurokawa H; Zhang M; Matsumoto S; Yamashita Y; Tomoyose T; Tanaka T; Fukuyama H; Takahashi T
    J Oral Pathol Med; 2005 Jul; 34(6):329-33. PubMed ID: 15946179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution and clinical significance of heparan sulfate proteoglycans in ovarian cancer.
    Davies EJ; Blackhall FH; Shanks JH; David G; McGown AT; Swindell R; Slade RJ; Martin-Hirsch P; Gallagher JT; Jayson GC
    Clin Cancer Res; 2004 Aug; 10(15):5178-86. PubMed ID: 15297422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of syndecan-1 expression in dysplasia and squamous cell carcinoma of the oral cavity.
    Jackson LL; Wade Z; Hessler RB; Abdelsayed R; Rogers JB; Gourin CG
    Laryngoscope; 2007 May; 117(5):868-71. PubMed ID: 17473685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological study of the expression of syndecan-1 in invasive breast carcinomas. correlation with extracellular matrix components.
    Tsanou E; Ioachim E; Briasoulis E; Charchanti A; Damala K; Karavasilis V; Pavlidis N; Agnantis NJ
    J Exp Clin Cancer Res; 2004 Dec; 23(4):641-50. PubMed ID: 15743035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression of E-cadherin at the invasive tumor front of oral squamous cell carcinoma: immunohistochemical and RT-PCR analysis with clinicopathological correlation.
    Wang X; Zhang J; Fan M; Zhou Q; Deng H; Aisharif MJ; Chen X
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Apr; 107(4):547-54. PubMed ID: 19327640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological pattern of mandibular invasion by oral squamous cell carcinoma.
    Wong RJ; Keel SB; Glynn RJ; Varvares MA
    Laryngoscope; 2000 Jan; 110(1):65-72. PubMed ID: 10646718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low p27Kip1 expression is associated with poor prognosis in oral squamous cell carcinoma.
    Harada K; Supriatno ; Yoshida H; Sato M
    Anticancer Res; 2002; 22(5):2985-9. PubMed ID: 12530030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue microarray analysis reveals prognostic significance of syndecan-1 expression in prostate cancer.
    Zellweger T; Ninck C; Mirlacher M; Annefeld M; Glass AG; Gasser TC; Mihatsch MJ; Gelmann EP; Bubendorf L
    Prostate; 2003 Apr; 55(1):20-9. PubMed ID: 12640657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis-associated markers and clinical outcome in human oral squamous cell carcinomas.
    Kato K; Kawashiri S; Yoshizawa K; Kitahara H; Yamamoto E
    J Oral Pathol Med; 2008 Jul; 37(6):364-71. PubMed ID: 18410312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
    Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
    Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stromal syndecan-1 expression is an adverse prognostic factor in oral carcinomas.
    Máthé M; Suba Z; Németh Z; Tátrai P; Füle T; Borgulya G; Barabás J; Kovalszky I
    Oral Oncol; 2006 May; 42(5):493-500. PubMed ID: 16364677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fragile histidine triad expression in oral squamous cell carcinoma and precursor lesions.
    Kujan O; Oliver R; Roz L; Sozzi G; Ribeiro N; Woodwards R; Thakker N; Sloan P
    Clin Cancer Res; 2006 Nov; 12(22):6723-9. PubMed ID: 17121892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nerve growth factor receptor (p75 NTR) and pattern of invasion predict poor prognosis in oral squamous cell carcinoma.
    Søland TM; Brusevold IJ; Koppang HS; Schenck K; Bryne M
    Histopathology; 2008 Jul; 53(1):62-72. PubMed ID: 18540978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.